Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02913430
Title Phase II Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Pittsburgh

estrogen-receptor positive breast cancer


Fulvestrant + Palbociclib

Palbociclib + Tamoxifen

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.